Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Laromustine

Laromustine

Laromustine structure

Laromustine 

structure
  • CAS No:

    173424-77-6

  • Formula:

    C6H14ClN3O5S2

  • Chemical Name:

    Laromustine

  • Synonyms:

    Methanesulfonic acid,1-(2-chloroethyl)-2-[(methylamino)carbonyl]-2-(methylsulfonyl)hydrazide;101M;VNP 40101M;Cloretazine;Laromustine;Onrigin

Description

VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.|Laromustine is a sulfonyl hydrazine prodrug with antineoplastic activity. Laromustine releases the DNA chloroethylating agent 90CE after entering the blood stream; 90CE chloroethylates alkylates the O6 position of guanine, resulting in DNA crosslinking, strand breaks, chromosomal aberrations, and disruption of DNA synthesis. Intracellular metabolism of this agent also releases methyl isocyanate which inhibits O6-alkyl-guanine transferase, an enzyme involved with DNA repair.

Laromustine Basic Attributes

307.77

307.78

14J2G0U3NQ

734246

DTXSID30169614

C2653

Characteristics

121

1.55530

1.527±0.06 g/cm3(Predicted)

1.546

Drug Information

Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), colorectal cancer, leukemia (lymphoid), leukemia (myeloid), lung cancer, myelodysplastic syndrome, pediatric indications, and solid tumors.

VNP40101M is a small molecule that works by damaging DNA. It releases the DNA chloroethylating agent 90CE after entering the blood stream. 90CE chloroethylates the O6 position of guanine residues, ultimately resulting in an interstrand DNA cross-link. Interstrand DNA cross-links are difficult to repair and are toxic to cells. VNP40101M demonstrates a broad spectrum of anticancer activity in preclinical studies, including activity in selected cell lines resistant to other alkylating agents such as BCNU, cyclophosphamide and melphalan. In preclinical studies, Cloretazine (VNP40101M) has been combined with other anticancer agents such as cytarabine (Ara-C). In addition, Cloretazine (VNP40101M) or its metabolite, has been shown to be capable of crossing the blood brain barrier in preclinical models.

1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-((2-methylamino)carbonyl)hydrazine

Computed Properties

Molecular Weight:307.8
XLogP3:-0.8
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:5
Exact Mass:307.0063406
Monoisotopic Mass:307.0063406
Topological Polar Surface Area:121
Heavy Atom Count:17
Complexity:463
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.